UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000014071
Receipt number R000016370
Scientific Title A phase II study of capecitabin plus cisplatin therapy for advanced gastric cancer with multiple lymph node metastases (OGSG 1401)
Date of disclosure of the study information 2014/05/26
Last modified on 2022/09/25 16:38:31

No. Disposal Last modified on Item of update
1 Insert 2014/05/26 16:50:01
2 Update 2015/06/10 00:11:43 Recruitment status
Date of protocol fixation
Anticipated trial start date
3 Update 2015/06/10 00:15:54 Email
Email
Institutions
4 Update 2015/12/03 21:09:38 Organization
Organization
Address
Address
TEL
Institutions
5 Update 2016/05/26 22:24:37 Name of primary person or sponsor
Organization
6 Update 2017/01/08 01:03:54 Recruitment status
7 Update 2018/05/01 00:01:03 Email
Email
8 Update 2018/05/10 20:36:54 Email
Email
9 Update 2018/08/01 20:10:28 UMIN ID1
10 Update 2018/08/01 20:14:33 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
11 Update 2018/08/08 19:21:11 Organization
Organization
Division name
Address
Address
TEL
Email
Address
Address
12 Update 2020/01/05 21:06:28 Recruitment status
Date of IRB
Date analysis concluded
13 Update 2020/01/05 21:07:31 Number of participants that the trial has enrolled
14 Update 2020/01/22 22:36:01 Anticipated trial start date
15 Update 2021/08/22 20:54:34 Publication of results
URL related to results and publications
16 Update 2022/07/24 10:20:27 Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
17 Update 2022/07/24 10:22:17 Recruitment status
Last follow-up date
18 Update 2022/07/24 10:33:41 URL releasing protocol
Adverse events
Outcome measures
Outcome measures
19 Update 2022/09/25 16:38:31 Results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures